GENFIT's Elafibranor (Iqirvo®) Granted EU Approval as Pioneer Treatment for PBC Post U.S. FDA Nod
Sep 23, 2024
Fda Invest Advisor
Vigil Neuroscience Receives Green Light from FDA for VG-3927 Clinical Trial
Sep 18, 2024
BridgeBio's Infigratinib Granted FDA Breakthrough Therapy Designation for Achondroplasia Treatment
Sep 17, 2024
QuidelOrtho Enhances Its Infectious Disease Lineup With FDA Approval for New Syphilis Test
Aug 31, 2024
ARS Pharmaceuticals Announces FDA Approval of Needle-Free Epinephrine Spray 'neffy'
Aug 10, 2024
Bionomics Advances BNC210 for PTSD after Positive FDA Phase 2 Meeting
Jul 31, 2024
FDA Issues Complete Response Letter to Novo Nordisk for Icodec Insulin
Jul 11, 2024
Arcutis Biotherapeutics Gains FDA Approval for ZORYVE® Cream to Treat Atopic Dermatitis
Jul 10, 2024
Mainz Biomed Shares Surge on FDA Breakthrough Device Submission News
Jul 10, 2024
Nyxoah Submits PMA Final Module for OSA Solution Genio to US FDA
Jul 1, 2024
Nyxoah Excels in Q1 2024 Performing Strong Financially and Advancing Clinically Towards FDA Approval
May 15, 2024
Inhibikase Therapeutics Advances with FDA Recognition of IkT-001Pro for Pulmonary Arterial Hypertension Treatment
May 9, 2024
IceCure Medical Inches Closer to FDA Nod with Promising ICE3 Trial Data on Cryoablation Therapy
Apr 27, 2024
FDA Approves Wegovy® for Cardiovascular Risk Reduction in Overweight or Obese Patients with Established Heart Disease
Mar 9, 2024
Quoin Pharmaceuticals Stock Surges Following FDA Approval for Teen Participation in Clinical Studies
Mar 5, 2024
FDA Approves Arcutis' Zoryve for Seborrheic Dermatitis Treatment
Dec 20, 2023
Harvard Law Expert Warns of Impending Conflict Between State Psychedelic Laws and FDA Regulation
Dec 13, 2023
Novartis Secures FDA Approval for PNH Treatment Fabhalta
Dec 7, 2023
FDA Finds Unsanitary Conditions at Eyedrop Manufacturer, Prompting Recall
Nov 17, 2023
ONWARD® Delivers Stellar Q3 Business Update and Progress Report for 2023
Nov 16, 2023